179 related articles for article (PubMed ID: 8841439)
1. Development and standardization of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA). A report on the second phase of an international cooperative study on the standardization of ANCA assays.
Hagen EC; Andrassy K; Csernok E; Daha MR; Gaskin G; Gross WL; Hansen B; Heigl Z; Hermans J; Jayne D; Kallenberg CG; Lesavre P; Lockwood CM; Lüdemann J; Mascart-Lemone F; Mirapeix E; Pusey CD; Rasmussen N; Sinico RA; Tzioufas A; Wieslander J; Wiik A; Van der Woude FJ
J Immunol Methods; 1996 Sep; 196(1):1-15. PubMed ID: 8841439
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.
Hagen EC; Daha MR; Hermans J; Andrassy K; Csernok E; Gaskin G; Lesavre P; Lüdemann J; Rasmussen N; Sinico RA; Wiik A; van der Woude FJ
Kidney Int; 1998 Mar; 53(3):743-53. PubMed ID: 9507222
[TBL] [Abstract][Full Text] [Related]
3. The value of indirect immunofluorescence and solid phase techniques for ANCA detection. A report on the first phase of an international cooperative study on the standardization of ANCA assays. EEC/BCR Group for ANCA Assay Standardization.
Hagen EC; Andrassy K; Chernok E; Daha MR; Gaskin G; Gross W; Lesavre P; Lüdemann J; Pusey CD; Rasmussen N
J Immunol Methods; 1993 Feb; 159(1-2):1-16. PubMed ID: 8445241
[TBL] [Abstract][Full Text] [Related]
4. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.
Xin G; Zhao MH; Wang HY
Clin Diagn Lab Immunol; 2004 May; 11(3):559-62. PubMed ID: 15138182
[TBL] [Abstract][Full Text] [Related]
5. Testing and reporting antineutrophil cytoplasmic antibodies (ANCA) in treated vasculitis and non-vasculitic disease.
Savige J; Trevisin M; Pollock W
J Immunol Methods; 2018 Jul; 458():1-7. PubMed ID: 29486145
[TBL] [Abstract][Full Text] [Related]
6. International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA).
Savige J; Gillis D; Benson E; Davies D; Esnault V; Falk RJ; Hagen EC; Jayne D; Jennette JC; Paspaliaris B; Pollock W; Pusey C; Savage CO; Silvestrini R; van der Woude F; Wieslander J; Wiik A
Am J Clin Pathol; 1999 Apr; 111(4):507-13. PubMed ID: 10191771
[TBL] [Abstract][Full Text] [Related]
7. Antineutrophil cytoplasmic antibody (ANCA) testing of routine sera varies in different laboratories but concordance is greater for cytoplasmic fluorescence (C-ANCA) and myeloperoxidase specificity (MPO-ANCA).
Pollock W; Jovanovich S; Savige J
J Immunol Methods; 2009 Aug; 347(1-2):19-23. PubMed ID: 19490915
[TBL] [Abstract][Full Text] [Related]
8. Antineutrophil cytoplasmic antibodies (ANCA) and systemic vasculitis: update of assays, immunopathogenesis, controversies, and report of a novel de novo ANCA-associated vasculitis after kidney transplantation.
Schultz DR; Diego JM
Semin Arthritis Rheum; 2000 Apr; 29(5):267-85. PubMed ID: 10805352
[TBL] [Abstract][Full Text] [Related]
9. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis.
Csernok E; Ahlquist D; Ullrich S; Gross WL
Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006
[TBL] [Abstract][Full Text] [Related]
10. A novel capture-ELISA for detection of anti-neutrophil cytoplasmic antibodies (ANCA) based on c-myc peptide recognition in carboxy-terminally tagged recombinant neutrophil serine proteases.
Lee AS; Finkielman JD; Peikert T; Hummel AM; Viss MA; Specks U
J Immunol Methods; 2005 Dec; 307(1-2):62-72. PubMed ID: 16242707
[TBL] [Abstract][Full Text] [Related]
11. Indirect immunofluorescence (IIF) of normal washed peripheral blood cells to demonstrate antineutrophil cytoplasmic antibodies (ANCA).
Paspaliaris B; Pamio M; Savige J
J Clin Pathol; 2000 Oct; 53(10):774-7. PubMed ID: 11064672
[TBL] [Abstract][Full Text] [Related]
12. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives.
Radice A; Vecchi M; Bianchi MB; Sinico RA
Clin Exp Rheumatol; 2000; 18(6):707-12. PubMed ID: 11138332
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease.
Merkel PA; Polisson RP; Chang Y; Skates SJ; Niles JL
Ann Intern Med; 1997 Jun; 126(11):866-73. PubMed ID: 9163287
[TBL] [Abstract][Full Text] [Related]
14. A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies.
Savige JA; Paspaliaris B; Silvestrini R; Davies D; Nikoloutsopoulos T; Sturgess A; Neil J; Pollock W; Dunster K; Hendle M
J Clin Pathol; 1998 Aug; 51(8):568-75. PubMed ID: 9828813
[TBL] [Abstract][Full Text] [Related]
15. [Rapid-detection GBM-ANCA ELISA. An emergency tool for the early diagnosis of type I and II rapidly progressive glomerulonephritis].
Arranz O; Ara J; Rodríguez R; Poveda R; Serra A; Solé-Amigó J; Fort J; Mirapeix E; Darnell A
Nefrologia; 2001; 21(4):349-54. PubMed ID: 11816510
[TBL] [Abstract][Full Text] [Related]
16. Use of proteinase 3 purified by reverse phase HPLC to detect autoantibodies in systemic vasculitis.
Gaskin G; Kendal H; Coulthart A; Turner N; Pusey CD
J Immunol Methods; 1995 Mar; 180(1):25-33. PubMed ID: 7897245
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study.
Csernok E; Holle J; Hellmich B; Willem J; Tervaert C; Kallenberg CG; Limburg PC; Niles J; Pan G; Specks U; Westman K; Wieslander J; De Groot K; Gross WL
Rheumatology (Oxford); 2004 Feb; 43(2):174-80. PubMed ID: 14585921
[TBL] [Abstract][Full Text] [Related]
18. Human mast cells expressing recombinant proteinase 3 (PR3) as substrate for clinical testing for anti-neutrophil cytoplasmic antibodies (ANCA).
Specks U; Wiegert EM; Homburger HA
Clin Exp Immunol; 1997 Aug; 109(2):286-95. PubMed ID: 9276524
[TBL] [Abstract][Full Text] [Related]
19. Some patients with anti-myeloperoxidase autoantibodies have a C-ANCA pattern.
Segelmark M; Baslund B; Wieslander J
Clin Exp Immunol; 1994 Jun; 96(3):458-65. PubMed ID: 7516271
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive method to purify three major ANCA antigens: proteinase 3, myeloperoxidase and bactericidal/permeability-increasing protein from human neutrophil granule acid extract.
Zhao MH; Lockwood CM
J Immunol Methods; 1996 Oct; 197(1-2):121-30. PubMed ID: 8890899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
